Cetuximab combined with radiotherapy: An alternative to chemoradiotherapy for patients with locally advanced squamous cell carcinomas of the head and neck?

This publication has 74 references indexed in Scilit:

• Current clinical outcomes demand new treatment options for SCCHN
  Annals of Oncology, 2005
• Global Cancer Statistics, 2002
  CA: A Cancer Journal for Clinicians, 2005
• Chemoradiation after Surgery for High-Risk Head and Neck Cancer Patients: How Strong Is the Evidence?
  The Oncologist, 2005
• Choosing a concomitant chemotherapy and radiotherapy regimen for squamous cell head and neck cancer: A systematic review of the published literature with subgroup analysis
  Head & Neck, 2001
• Chemotherapy in the management of squamous-cell carcinoma of the head and neck
  The Lancet Oncology, 2001
• A radiation therapy oncology group (RTOG) phase III randomized study to compare hyperfractionation and two variants of accelerated fractionation to standard fractionation radiotherapy for head and neck squamous cell carcinomas: first report of RTOG 9003
  Published by Elsevier ,2000
• Simultaneous radiochemotherapy versus radiotherapy alone in advanced head and neck cancer: a randomized multicenter study.
  Journal of Clinical Oncology, 1998
• A phase III randomized trial comparing concurrent chemotherapy and radiotherapy with radiotherapy alone in resectable stage III and IV squamous cell head and neck cancer: Preliminary results
  Head & Neck, 1997
• Accelerated fractionation (AF) compared to conventional fractionation (CF) improves loco-regional control in the radiotherapy of advanced head and neck cancers: results of the EORTC 22851 randomized trial
  Radiotherapy and Oncology, 1997
• Hyperfractionation versus conventional fractionation in oropharyngeal carcinoma: final analysis of a randomized trial of the EORTC cooperative group of radiotherapy
  Radiotherapy and Oncology, 1992